Jubilant Life Sciences gains on hiking prices of certain intermediates by up to 15%

21 Dec 2016 Evaluate

Jubilant Life Sciences is currently trading at Rs. 612.45, up by 16.15 points or 2.71% from its previous closing of Rs. 596.30 on the BSE.

The scrip opened at Rs. 607.15 and has touched a high and low of Rs. 618.50 and Rs. 605.95 respectively. So far 50,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 726.40 on 01-Dec-2016 and a 52 week low of Rs. 272.50 on 20-Jan-2016.

Last one week high and low of the scrip stood at Rs. 653.00 and Rs. 592.90 respectively. The current market cap of the company is Rs. 9,759.16 crore.

The promoters holding in the company stood at 54.02%, while Institutions and Non-Institutions held 26.26% and 19.72% respectively.

Jubilant Life Sciences has increased price up to 15% for Beta Picoline, 3-Cyanopyridine and Vitamin B3 (Niacin & Niacinamide) with immediate effect, for non-contract customers and wherever existing contracts permit.

Jubilant Life Sciences is an integrated global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients.

Jubilant Pharmova Share Price

1130.85 -0.25 (-0.02%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.